These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 6223384)

  • 21. [Autologous mixed lymphocyte culture (AMLC)].
    Volk HD; Grunow R
    Allerg Immunol (Leipz); 1984; 30(2):60-73. PubMed ID: 6237558
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Antilymphocytic antibodies in Behcet's syndrome].
    Lavalle C; Fraga A; Alcocer J; Gudiño J; Lifshitz A
    Prensa Med Mex; 1978; 43(3-4):104-9. PubMed ID: 310117
    [No Abstract]   [Full Text] [Related]  

  • 23. [The lymphoblastic transformation test with autologous saliva in Behcet's syndrome].
    Amor B; Kahan A; Delbarre F
    Rev Rhum Mal Osteoartic; 1974 May; 41(5):309-13. PubMed ID: 4845399
    [No Abstract]   [Full Text] [Related]  

  • 24. [Lymphocyte subsets and immunoglobulins in patients with Behçet disease].
    Sunakawa M; Okinami S
    Nippon Ganka Gakkai Zasshi; 1985 May; 89(5):688-91. PubMed ID: 3875217
    [No Abstract]   [Full Text] [Related]  

  • 25. Aspects of lymphocyte function in Behçet's disease.
    Haim S; Mekori T; Sobel JD; Robinson E
    Dermatologica; 1976; 153(1):34-7. PubMed ID: 1086808
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An update on Behçet's disease.
    Kalayciyan A; Zouboulis C
    J Eur Acad Dermatol Venereol; 2007 Jan; 21(1):1-10. PubMed ID: 17207160
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prospective determination of T-cell responses to S-antigen in Behçet's disease patients and controls.
    de Smet MD; Dayan M
    Invest Ophthalmol Vis Sci; 2000 Oct; 41(11):3480-4. PubMed ID: 11006242
    [TBL] [Abstract][Full Text] [Related]  

  • 28. NF-kappaB protects Behçet's disease T cells against CD95-induced apoptosis up-regulating antiapoptotic proteins.
    Todaro M; Zerilli M; Triolo G; Iovino F; Patti M; Accardo-Palumbo A; di Gaudio F; Turco MC; Petrella A; de Maria R; Stassi G
    Arthritis Rheum; 2005 Jul; 52(7):2179-91. PubMed ID: 15986355
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Can you catch Behçet's disease?
    Fortune F
    J Lab Clin Med; 2003 Jan; 141(1):5-6. PubMed ID: 12518164
    [No Abstract]   [Full Text] [Related]  

  • 30. Surface molecules involved in self-recognition and T cell activation in the autologous mixed lymphocyte reaction.
    Romain PL; Schlossman SF; Reinherz EL
    J Immunol; 1984 Sep; 133(3):1093-100. PubMed ID: 6235279
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Cellular immune status and microphage function in Behçet's disease].
    Djawari D; Hornstein OP
    Z Hautkr; 1980 Mar; 55(5):271-92. PubMed ID: 6996366
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pathogenesis and therapy of Behçet's disease.
    Emmi L; Brugnolo F; Marchione T
    Ann Ital Med Int; 1997; 12(1):20-5. PubMed ID: 9284594
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cellular autoimmunity to retinal specific antigens in Behçet's disease.
    Hamzaoui K; Mili Boussen E; Hamzaoui A; Ouertani A; Chabbou A; Ayed K
    Tunis Med; 1998 Apr; 76(4):66-70. PubMed ID: 9739193
    [No Abstract]   [Full Text] [Related]  

  • 34. [Studies on interferon in Behçet's disease].
    Kato F
    Hokkaido Igaku Zasshi; 1983 Jan; 58(1):63-73. PubMed ID: 6404745
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Autologous rosette-forming T cells as the responding cells in human autologous mixed-lymphocyte reaction.
    Palacios R; Llorente L; Alarcón-Segovia D; Ruíz-Arguelles A; Díaz-Jouanen E
    J Clin Invest; 1980 Jun; 65(6):1527-30. PubMed ID: 6447710
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of Bcl-2 in inflammatory sites from patients with active Behçet's disease.
    Hamzaoui K; Hamzaoui A; Zakraoui L; Chabbou A
    Mediators Inflamm; 1999; 8(2):101-6. PubMed ID: 10704147
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Responder cells in the human autologous mixed lymphocyte reaction (AMLR). Characterization and interactions in healthy individuals and patients with systemic lupus erythematosus.
    Smolen JS; Siminovitch K; Luger TA; Steinberg AD
    Behring Inst Mitt; 1983 May; (72):135-42. PubMed ID: 6242332
    [TBL] [Abstract][Full Text] [Related]  

  • 38. T-gammadelta receptor restriction in peripheral lymphocytes of patients with Behçet's disease.
    van Hagen PM; Hooijkaas H; Vd Beemd MW; Verjans G; Baarsma GS
    Adv Exp Med Biol; 2003; 528():267-8. PubMed ID: 12918704
    [No Abstract]   [Full Text] [Related]  

  • 39. The mechanism of hyperchemotaxis in Behçet's disease.
    Takeuchi A; Kobayashi K; Mori M; Mizushima Y
    J Rheumatol; 1981; 8(1):40-4. PubMed ID: 7218257
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Abnormal B cell function in patients with Behçet's disease.
    Suzuki N; Sakane T; Ueda Y; Tsunematsu T
    Arthritis Rheum; 1986 Feb; 29(2):212-9. PubMed ID: 3485432
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.